Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yukio Yokoi is active.

Publication


Featured researches published by Yukio Yokoi.


Journal of Gastroenterology and Hepatology | 1994

Immunoreactivity to M2 proteins in antimitochondrial antibody-negative patients with primary biliary cirrhosis.

Noriyuki Kitami; Hideo Ishii; Hidetake Shimizu; Hiroyasu Adachi; Toshiyuki Komada; Hideaki Mikami; Yukio Yokoi; Nobuhiro Sato

Abstract Although antimitochondrial auto‐antibodies are characteristically present in the serum of patients with primary biliary cirrhosis (PBC), there is a discrepancy between the positivity for antimitochondrial antibody (AMA) and that for anti‐M2 auto‐antibody. In an attempt to explain the discrepancy, this study investigates the relationship between the AMA titre, determined by indirect immunofluorescence, and immunoreactivity to four inner mitochondrial membrance proteins (M2 proteins) with molecular weights of 70, 50, 47, and 40 kDa in 129 patients with PBC. Antimitochondrial antibody positivity was identified in 114 (88%) of 129 patients with clinically and histologically confirmed PBC. There were no significant differences between the AMA‐negative and AMA‐positive groups in clinical characteristics or histologically determined disease stage. Immunoblot analysis showed that all patients had anti‐M2 auto‐antibodies to one or more of the four M2 proteins. Nine (60%) of the 15 AMA‐negative patients had antibodies to only one M2 protein (either 70 or 47 kDa). In contrast, 34 (53%) of the 64 patients with high AMA titres ( 1: 320) had antibodies to all four M2 proteins. There was a significant rank correlation between the AMA titre and the number of antibodies to M2 proteins (P < 0.01). These findings indicate that the AMA titre is not influenced by the immunogenicity of M2 protein but by the number of M2 proteins that elicit an antibody response and that decreased immunoreactivity to M2 proteins may induce AMA negativity in PBC serum samples.


Journal of Gastroenterology and Hepatology | 1998

Hepatic stellate cell contraction is inhibited by lipo-prostaglandin E1 in vitro

Xian-En Wang; Sumio Watanabe; Hirosumi Oide; Miyoko Hirose; Tomoko Itatsu; Taro Osada; Yoshiro Takazakura; Yukio Yokoi; N. Sato

Prostaglandin E1 (PGE1) has been reported to have, experimentally and clinically, a protective effect against liver damage. This effect may result from the relaxation of hepatic stellate cells, whose contraction induces vasoconstriction of hepatic sinusoids. However, prostaglandins are unstable and a new drug delivery system is necessary to administer a sufficient amount of prostaglandin to achieve a protective effect in the liver. The aim of the study is to investigate the effects of lipo‐prostaglandin E1 (lipo‐PGE1) which has a novel drug delivery system on the stellate cell contraction induced by endothelin‐1 in vitro. Lipo‐PGE1 inhibited endothelin‐1‐induced stellate cell contraction in concentrations of 10, 30 and 50 ng/mL. Therefore, lipo‐PGE1 may show a cytoprotective effect in the liver through the relaxation of stellate cells and an increase in the hepatic sinusoidal blood flow.


Journal of Gastroenterology and Hepatology | 1998

Oesophageal hiatal hernia‐induced hydropneumothorax

Toru Fukuda; Yukio Yokoi; Fumiaki Takiura; Sumio Watanabe

The patient presented with acute and constant abdominal pain. He had had a lobectomy of the left lung three months before. On the 4th day in hospital the pain increased and he went into temporary shock. The next day a hydropneumothorax and incarcerated stomach were revealed by chest X‐ray and computed tomography. He was transferred to the University Hospital immediately and underwent an operation. The diagnosis was an incarcerated para‐oesophageal hernia with hydropneumothorax and perforation of the stomach. As a para‐oesophageal hernia may be fatal, is important to diagnose and treat it early.


Journal of Gastroenterology and Hepatology | 1993

Marked retention of indocyanine green and sulfobromophthalein with chronic persistent hepatitis.

Kenichi Ikejima; Shoichi Ichikawa; Tsuneo Kitamura; Sumio Watanabe; Miyoko Hirose; Yukio Yokoi; Shigeyuki Uchida; Hirosumi Oide; Hideo Suzuki; Noriyuki Kitami; Nobuhiro Sato

A hepatitis B virus (HBV) carrier with marked retention of indocyanine green (ICG) and sulfobromophthalein (BSP) was admitted to our hospital for assessment of liver function. On admission, he was asymptomatic and blood chemistry tests showed normal values for transaminases and bilirubin. Serum hepatitis B surface antigen (HBsAg) and antibody to hepatitis B e antigen (anti‐HBe) were positive. A history of drug abuse or alcoholism was denied. Dye excretion tests revealed marked retention of ICG (R15= 70%) and BSP (R45= 23%). Histopathological examination of a liver biopsy specimen obtained during laparoscopic observation showed chronic persistent hepatitis (CPH). Familial research of the patient failed to prove the existence of dye excretory defect in his siblings. Usual cases of CPH due to continuous HBV infection do not show such severe disturbance of organic anion transport.


Hepatology | 1984

Immunocytochemical Detection of Desmin in Fat‐Storing Cells (Ito Cells)

Yukio Yokoi; Toshihiko Namihisa; Hlroyuki Kuroda; Ikutoshi Komatsu; Akihisa Miyazaki; Sumio Watanabe; Koh Usui


Liver | 2008

Distribution of Ito cells in experimental hepatic fibrosis.

Yukio Yokoi; Toshihiko Namihisa; Kenichiro Matsuzaki; Akihisa Miyazaki; Yasushi Yamaguchi


Internal Medicine | 1995

Immunological Study of Anti-M2 in Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis

Noriyuki Kitami; Toshiyuki Komada; Hideo Ishii; Hidetake Shimizu; Hiroyasu Adachi; Yasushi Yamaguchi; Tsuneo Kitamura; Hirosumi Oide; Akihisa Miyazaki; Masakuni Ishikawa; Keiichiro Endo; Sumio Watanabe; Yukio Yokoi; Nobuhiro Sato


American Journal of Anatomy | 1988

Reticular meshwork of the spleen in rats studied by electron microscopy

Hiroaki Saito; Yukio Yokoi; Sumio Watanabe; Junko Tajima; Heroyuki Kuroda; Toshihiko Namihisa


Acta Histochemica Et Cytochemica | 1981

ACTIN FILAMENTS OF HEPATOCYTES IN EXPERIMENTAL RAT CHOLESTASIS : OBSERVATIONS USING A FLUORESCENT STAINING METHOD BY DACM LABELED HEAVY MEROMYOSIN

Kohei Tamura; H. Kuroda; Sumio Watanabe; Yukio Yokoi


Acta Histochemica Et Cytochemica | 1986

IMMUNOLOGICAL CROSS-SPECIES REACTIVITY OF DESMIN IN FAT-STORING CELLS (ITO CELLS) OF VERTEBRATES

Akihisa Miyazaki; Yukio Yokoi; Kenichiro Matsuzaki; H. Kuroda

Collaboration


Dive into the Yukio Yokoi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge